Docteur Flora SAGEZ

Bibliographie

• Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014

  2020

  ArticleAutoimmunity Reviews

• The world-wide burden of musculoskeletal diseases: a systematic analysis of the World Health Organization Burden of Diseases Database.

  2019

  ArticleAnnals of the Rheumatic Diseases

• Spotlight on anifrolumab and its potential for the treatment of moderate-to-severe systemic lupus erythematosus: evidence to date

  2019

  ArticleDrug Design, Development and Therapy

• 10 most important contemporary challenges in the management of SLE.

  2019

  ArticleLupus science & medicine

• Defective BTLA functionality is rescued by restoring lipid metabolism in lupus CD4+ T cells

  2018

  ArticleJCI Insight

• Stratégies d’arrêt ou de réduction des biomédicaments dans la polyarthrite rhumatoïde en rémission

  2017

  ArticleLa Revue de Médecine Interne

Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).

Localisation des cabinets

Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.

Lieux de consultation

• HOPITAL DE HAUTEPIERRE

  1 Avenue MOLIERE, 67200 Strasbourg

  ☎ 0388116768Hospitalier🏥 Voir cet établissement
  113 m113 m192 m

  © OpenStreetMap · Photos Wikimedia Commons (CC)

  📷 Street View ↗🗺️ Maps ↗OSM ↗

• SELARL CABINET DE RHUMATOLOGIE DU DOCTEUR FLORA SAGEZ

  5 RUE DE LA GARE, 67600 Sélestat

  Libéral
  38 m47 m49 m51 m

  © OpenStreetMap · Photos Wikimedia Commons (CC)

  📷 Street View ↗🗺️ Maps ↗OSM ↗

Tarifs & secteur de conventionnement

Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).

Prendre rendez-vous & contact

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Top publications · les plus citées

• 1

  The world-wide burden of musculoskeletal diseases: a systematic analysis of the World Health Organization Burden of Diseases Database

  Annals of the rheumatic diseases · 2019

  📚 231 citations🎯 RCR 14.53Top 1% NIH
• 2

  Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014

  Autoimmunity reviews · 2020

  📚 111 citations🎯 RCR 5.86Top 6% NIH
• 3

  10 most important contemporary challenges in the management of SLE

  Lupus science & medicine · 2019

  📚 60 citations🎯 RCR 3.20Top 15% NIH🔓 Open Access📄 PDF gratuit ↗

  Lire l'abstract Crossref ↓

  From a 1-year survival of less than 50% before the discovery of glucocorticoids to over 90% at 10 years in most dedicated centres, the spectrum of SLE has profoundly evolved. Despite this improvement, several major challenges currently remain. The aim of this review is to analyse what are, according to us, the 10 most important contemporary challenges in the management of SLE. Among those are the need to treat to target to favour disease remission (or low disease activity), limit the use of glucocorticoids, derive more comprehensive tools for the evaluation of disease activity, develop more effective drugs (yielding successful trials), dissect the heterogeneity of the disease both at the molecular and genetic levels, identify relevant biomarkers for individualised treatment, manage fertility and pregnancy, tackle comorbidities such as cardiovascular risk, the prevention of infections and osteoporosis, improve the network of care (from the patients’ perspective), and favour a holistic approach (integrating fatigue, adherence to treatment, physical activity). Altogether, these 10 contemporary challenges in SLE may be considered as a roadmap for those involved in the daily care of patients with SLE, as well as for researchers who may wish to contribute to an improved management of this rare and complex disease.

Publications scientifiques (6) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Partager cette fiche